TMDX logo

TMDX
Transmedics Group Inc

6,803
Mkt Cap
$2.38B
Volume
1.15M
52W High
$156.00
52W Low
$60.11
PE Ratio
15.82
TMDX Fundamentals
Price
$68.94
Prev Close
$68.85
Open
$68.50
50D MA
$97.68
Beta
1.29
Avg. Volume
870,833.70
EPS (Annual)
$4.87
P/B
4.82
Rev/Employee
$674,269.49
$4,962.69
Loading...
Loading...
News
all
press releases
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire ANDOVER, Mass., May 21, 2026 ANDOVER, Mass., May 21, 2026 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a...
News Placeholder
More News
News Placeholder
TransMedics to Present at the William Blair 46th Annual Growth Stock Conference
TransMedics to Present at the William Blair 46th Annual Growth Stock Conference TransMedics to Present at the William Blair 46th Annual Growth Stock Conference PR Newswire ANDOVER, Mass., May 19...
News Placeholder
TransMedics Group (NASDAQ:TMDX) Given New $124.00 Price Target at Canaccord Genuity Group
Canaccord Genuity Group dropped their target price on TransMedics Group from $152.00 to $124.00 and set a 'buy' rating on the stock in a research report on Wednesday...
News Placeholder
TransMedics Group (NASDAQ:TMDX) Price Target Lowered to $120.00 at TD Cowen
TD Cowen reduced their target price on shares of TransMedics Group from $190.00 to $120.00 and set a "buy" rating for the company in a report on Wednesday...
News Placeholder
Stifel Nicolaus Cuts TransMedics Group (NASDAQ:TMDX) Price Target to $85.00
Stifel Nicolaus lowered their price target on TransMedics Group from $130.00 to $85.00 and set a "hold" rating for the company in a research report on Wednesday...
News Placeholder
Piper Sandler Issues Pessimistic Forecast for TransMedics Group (NASDAQ:TMDX) Stock Price
Piper Sandler reduced their price target on TransMedics Group from $160.00 to $120.00 and set an "overweight" rating on the stock in a report on Wednesday...
News Placeholder
TMDX Dips After Posting Q1 Earnings & Revenue Miss, Margins Fall
TransMedics' Q1 revenues rise 21% on strong OCS demand, but a sharp EPS miss and margin pressure send shares down despite continued logistics growth.
News Placeholder
TransMedics Group (NASDAQ:TMDX) Hits New 12-Month Low on Disappointing Earnings
TransMedics Group (NASDAQ:TMDX) Hits New 1-Year Low Following Weak Earnings...
News Placeholder
Needham & Company LLC Has Lowered Expectations for TransMedics Group (NASDAQ:TMDX) Stock Price
Needham & Company LLC lowered their price objective on TransMedics Group from $174.00 to $142.00 and set a "buy" rating on the stock in a research report on Wednesday...
News Placeholder
TransMedics Group (NASDAQ:TMDX) Downgraded to "Market Perform" Rating by Oppenheimer
Oppenheimer lowered TransMedics Group from an "outperform" rating to a "market perform" rating in a research report on Wednesday...
<
1
2
...
>

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available